June 10, 2018
Caladrius Biosciences, Bellerophon Therapeutics, Celsion, Albireo Pharma and Trillium Therapeutics were last week's top gainers on the NASDAQ Biotechnology Index.
June 10, 2018
MEI Pharma, Anavex Life Sciences, Trillium Therapeutics, Celldex Therapeutics and Ophthotech were last week's top gainers on the NASDAQ Biotechnology...
May 31, 2018
Here is a look at four stocks and a big ETF searching for novel therapies in the quest for the...
May 13, 2018
Helius Medical Technologies, vTv Therapeutics, Second Sight Medical Products, Depomed and Senomyx were last week's top gainers on the NASDAQ.
May 10, 2018
The firm highlights that the EV charging technology–which is currently at $2.1 billion–is projected to reach $8 billion by 2022.
April 29, 2018
Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 26, 2018
Although investment in Canadian fintech companies fell in Q1, overall venture capital investment set a new record of $1 billion...
April 24, 2018
Dr. John Burba of International Battery Metals discusses the lithium market and his company's lithium extraction technology.
April 17, 2018
Victory Square Technologies (CSE:VST) has announced that it will acquire 9.09 percent of the issued and outstanding shares of LocoNoco...
April 15, 2018
Novelion Therapeutics, EyePoint Pharmaceuticals, CytRx, Viking Therapeutics and AVEO Pharmaceuticals were last week's top gainers.